Can Lamotrigine be taken concurrently with Lurasidone?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: January 20, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Concurrent Use of Lamotrigine and Lurasidone

Yes, lamotrigine can be safely taken at the same time as lurasidone without clinically significant drug-drug interactions. These medications do not interact through hepatic enzyme systems, and their combination is commonly used in bipolar disorder management.

Pharmacological Compatibility

  • Lamotrigine's primary interactions occur with enzyme-inducing anticonvulsants (phenytoin, carbamazepine, barbiturates, primidone, topiramate, oxcarbazepine), not with atypical antipsychotics like lurasidone 1, 2.

  • Lurasidone is metabolized primarily through CYP3A4, while lamotrigine undergoes glucuronidation and does not significantly affect CYP450 enzymes 3, 2.

  • No pharmacokinetic interaction exists between lamotrigine and atypical antipsychotics, as lamotrigine does not induce or inhibit the metabolic pathways relevant to lurasidone 1, 4.

Clinical Context for Combination Therapy

  • This combination is clinically appropriate for bipolar disorder management, where lurasidone is approved for acute bipolar depression and can be combined with mood stabilizers like lamotrigine 1, 5.

  • Lurasidone has demonstrated efficacy in bipolar depression both as monotherapy and in combination with mood stabilizers, with minimal metabolic side effects 6, 5.

  • The combination may provide complementary benefits: lamotrigine for mood stabilization and depression prevention, and lurasidone for acute mood episodes and potential cognitive benefits 3, 5.

Practical Administration Considerations

  • Lurasidone must be taken with food (at least 350 calories) to ensure adequate absorption, while lamotrigine can be taken with or without food 3.

  • Continue standard lamotrigine titration protocols (typically starting at 25 mg and increasing gradually) to minimize rash risk, regardless of lurasidone co-administration 7.

  • Lurasidone requires no titration and is typically dosed at 40-80 mg once daily 3.

Monitoring Recommendations

  • Monitor for additive sedation, as both medications can cause somnolence, particularly early in treatment 3, 4.

  • Watch for akathisia and parkinsonism from lurasidone, especially during the first weeks of treatment 3.

  • No additional laboratory monitoring beyond standard protocols for each medication is required when used in combination 7.

Important Clinical Distinctions

  • This interaction profile differs markedly from lamotrigine's interaction with combined oral contraceptives, which significantly decrease lamotrigine levels and may require dosage adjustments 8, 7.

  • Unlike enzyme-inducing anticonvulsants that would require lurasidone dose adjustments, lamotrigine does not alter lurasidone pharmacokinetics 2, 4.

  • The combination does not increase risk for serious pharmacodynamic interactions like agranulocytosis, pancreatitis, or heat stroke that can occur with some other antiepileptic-antipsychotic combinations 4.

References

Guideline

Concurrent Use of Invega and Lamictal

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

Lurasidone: a clinical overview.

The Journal of clinical psychiatry, 2011

Research

Interactions between antiepileptics and second-generation antipsychotics.

Expert opinion on drug metabolism & toxicology, 2012

Research

Lurasidone in combination with lithium or valproate for the maintenance treatment of bipolar I disorder.

European neuropsychopharmacology : the journal of the European College of Neuropsychopharmacology, 2017

Guideline

Lamotrigine and Oral Contraceptive Interaction

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.